High serum levels of CXC (CXCL10) and CC (CCL2) chemokines in untreated essential hypertension

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 2, 2012, Pages 387-395

  Antonelli, Alessandro ^a   Fallahi, P ^a   Ferrari, S M ^a   Ghiadoni, L ^a   Virdis, A ^a   Mancusi, C ^a   Centanni, M ^b   Taddei, S ^a   Ferrannini, E ^a  

^a UNIVERSITY OF PISA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CCL2; CXCL10; Cytokines; Hypertension; Inflammation; Th1

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; CHEMOKINE; CXCL 10 CHEMOKINE; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SPHYGMOMANOMETER; PROTEIN MOTIF; SYSTOLIC BLOOD PRESSURE;

EID: 84863704124     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500208     Document Type: Article

References (21)

1. Salvetti A, Ghiadoni L. Guidelines forantihypertensive treatment: an update after the ALLHAT study. J Am Soc Nephrol 2004; 15(S)1:51-4.
2. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340:115-26. (Pubitemid 29054847)
3. Li JJ, Fang CH, Hui RT. Is hypertension an inflammatory disease? Med Hypotheses 2005; 64:236-40. (Pubitemid 40022654)
4. Schmid-Schonbein GW, Seiffge D, DeLano FA, Shen K, Zweifach BW. Leukocyte counts and activation in spontaneously hypertensive and normotensive rats. Hypertension 1991; 17:323-30.
5. Bush E, Maeda N, Kuziel WA, Dawson TC, Wilcox JN, DeLeon H, Taylor WR. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension 2000; 36:360-3.
6. Hilgers KF, Hartner A, Porst M, et al. Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. Kidney Int 2000; 58:2408-19.
7. Hilgers KF. Monocytes/macrophages in hypertension. J Hypertens 2002; 20:593-6. (Pubitemid 34913696)
8. Virdis A, Ghiadoni L, Plantinga Y, Taddei S, Salvetti A. C-reactive protein and hypertension: is there a causal relationship? Curr Pharm Des 2007; 13:1693-8. (Pubitemid 46979723)
9. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000; 12:121-7. (Pubitemid 30398626)
10. Antonelli A, Fallahi P, Rotondi M, et al. High serum levels of CXC chemokine ligand 10 in untreated essential hypertension. J Hum Hypertens 2008; 22:57981.
11. Karpus WJ, Lukacs NW, Kennedy KJ, Smith WS, Hurst SD, Barrett TA. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J Immunol 1997; 158:4129-36. (Pubitemid 127483911)
12. Kao J, Kobashigawa J, Fishbein MC, MacLellan WR, Burdick MD, Belperio JA, Strieter RM. Elevated serum levels of the CXCR3 chemokine ITAC are associated with the development of transplant coronary artery disease. Circulation 2003; 107:1958-61. (Pubitemid 36506066)
13. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Paolicchi A, Ferrannini E, Serio M. Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol 2005; 152:171-7. (Pubitemid 40309561)
14. Filippatos GS, Kardaras F. Chemokines and other novel inflammatory markers in hypertension: what can their plasma levels tell us? Int J Cardiol 2002; 83:21-3. (Pubitemid 34311873)
15. Grundy SM. Inflammation, hypertension, and the metabolic syndrome. JAMA 2003; 290:3000-2.
16. Peters W, Charo IF. Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice. Curr Opin Lipidol 2001; 12:175-80. (Pubitemid 32242925)
17. Parissis JT, Korovesis S, Giazitzoglou E, Kalivas P, Katritsis D. Plasma profiles of peripheral monocyte-related inflammatory markers in patients with arterial hypertension. Correlations with plasma endothelin-1. Int J Cardiol 2002; 83:13-21. (Pubitemid 34311872)
18. Suda T, Osajima A, Tamura M, et al. Pressure-induced expression of monocyte chemoattractant protein-1 through activation of MAP kinase. Kidney Int 2001; 60:1705-15. (Pubitemid 32999975)
19. Tucci M, Quatraro C, Frassanito MA, Silvestris F. Deregulated expression of monocyte chemoattractant protein-1 (MCP-1) in arterial hypertension: role in endothelial inflammation and atheromasia. J Hypertens 2006; 24:1307-18. (Pubitemid 43948330)
20. Sanchez O, Marcos E, Perros F, et al. Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2007; 176:1041-7. (Pubitemid 350127849)
21. Sardo MA, Campo S, Mandraffino G, et al. Tissue factor and monocyte chemoattractant protein-1 expression in hypertensive individuals with normal or increased carotid intima-media wall thickness. Clin Chem 2008; 54:814-23. (Pubitemid 351671606)